GSK plc (NYSE:GSK)
| 35.08 BATS BZX Real-Time Price As of 1:23pm ET |  +0.70 / +2.02%Today’s Change | 28.47 Today|||52-Week Range 43.70 | -0.18% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 36.5B | 37.5B | 38.9B | 41.1B | |
| Cost of Goods Sold | 11.1B | 10.3B | 10.5B | 10.7B | ||
| Depreciation And Amortization | 2.5B | 2.4B | 2.5B | 2.5B | ||
| Operating Expenses | Gross Income | 22.9B | 24.8B | 25.9B | 27.9B | |
| General Expenses | 16.1B | 15.6B | 15.6B | 17.2B | ||
| Research And Development | 5.2B | 4.7B | 5.0B | 4.9B | ||
| Total Operating Expenses | 29.7B | 28.3B | 28.6B | 30.4B | ||
| Non-Operating Expenses | Operating Income | 6.8B | 9.2B | 10.3B | 10.7B | |
| Extraordinary Credit | 47.3M | 191.1M | -- | -- | ||
| Extraordinary Charge | -7.2B | -7.1B | -5.5B | -4.0B | ||
| Interest Expense On Debt | 1.0B | 923.2M | 898.9M | 942.7M | ||
| Equity In Earnings | 21.4M | 6.7M | 16.7M | 41.3M | ||
| Other Expenses | 17.3B | 1.2B | 600.1M | 509.4M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 16.0B | 2.6B | 4.5B | 6.4B | |
| Income Taxes | -3.3B | -1.2B | -1.7B | -1.0B | ||
| Minority Interest | -76.3M | -201.9M | -820.3M | -564.0M | ||
| Net Income | 12.8B | 1.2B | 2.0B | 4.8B | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 2.4B | 2.4B | 2.4B | 2.5B | |
| Shares To Calculate EPS Diluted | 2.4B | 2.5B | 2.5B | 2.5B | ||
| Earnings Per Share | EPS | $5.32 | $0.51 | $0.81 | $1.97 | |
| EPS Diluted | $5.26 | $0.50 | $0.80 | $1.94 | ||
